Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|June 17, 2021
A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem CellsShenq-Shyang Huang, Wen-Ying Liao, Chung-Chi Hsu, et al.
Frontiers in Oncology|July 9, 2021
Corrigendum: A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem CellsShenq-Shyang Huang, Wen-Ying Liao, Chung-Chi Hsu, et al.
Expert Review of Gastroenterology & Hepatology|January 20, 2022
Percutaneous endoscopic gastrostomy prior to esophagectomy for esophageal cancer - a systematic review and meta-analysisHua-Chen Fang, Musa Hassan Farah, Sheng-Jie Shiue, et al.
Nutrients|July 27, 2022
Arthrospira Enhances Seroclearance in Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue through Modulation of TNF-α/IFN-γ ProfileSheng-Jie Shiue, Chao-Ling Cheng, Han-Shiang Shiue, et al.
The Journal of Pathology|August 30, 2019
The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosisChung-Chi Hsu, Wen-Ying Liao, Tze-Sian Chan, et al.
Molecular Oncology|January 27, 2024
ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cellsTze-Sian Chan, Li-Hsin Cheng, Chung-Chi Hsu, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 30, 2021
A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancerChung-Chi Hsu, Wen-Ying Liao, Kwang-Yu Chang, et al.
Oncogene|November 4, 2018
Correction: ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signalingVincent C Pai, Chung-Chi Hsu, Tze-Sian Chan, et al.
Oncogene|September 30, 2018
ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signalingVincent C Pai, Chung-Chi Hsu, Tze-Sian Chan, et al.
Journal of Medical Virology|March 18, 2026
Impact of Metabolic Associated Steatotic Liver Disease on Antiviral Therapy Outcomes on Chronic Hepatitis B Patients Receiving Antiviral TherapySheng-Jie Shiue, Tung-Han Ho, Hsin-Yi Lin, et al.
Pageof 3